Expert Opinion on Drug Safety, Volume 15, Issue 1 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 15, Issue 1 (2016)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Volume 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Pharmacotherapy in epilepsy – does gender affect safety?
Cecilie Johannessen Landmark & Svein I Johannessen
Pages: 1-4
Published online: 09 Dec 2015
AbstractforPharmacotherapy in epilepsy – does gender affect safety? | Full Text | References | PDF (184.7 KB)
  • 1443 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines
Omar Abdel-Rahman, Hesham ElHalawani & Shaimaa Essam-Eldin
Pages: 5-20
Published online: 29 Oct 2015
AbstractforS-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines | Full Text | References | PDF (1.5 MB)
  • 133 Views
  • 9 CrossRef citations
  • 0Altmetric

Reviews

Safety of medical treatments for endometriosis
Nicola Berlanda, Edgardo Somigliana, Paola Viganò & Paolo Vercellini
Pages: 21-30
Published online: 10 Dec 2015
AbstractforSafety of medical treatments for endometriosis | Full Text | References | PDF (237.9 KB)
  • 1202 Views
  • 46 CrossRef citations
  • 0Altmetric
Sexual dysfunction related to antiepileptic drugs in patients with epilepsy
Yong Yang & Xuefeng Wang
Pages: 31-42
Published online: 11 Nov 2015
AbstractforSexual dysfunction related to antiepileptic drugs in patients with epilepsy | Full Text | References | PDF (274.2 KB)
  • 886 Views
  • 35 CrossRef citations
  • 0Altmetric
Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani & Francesco Puppo
Pages: 43-52
Published online: 11 Nov 2015
AbstractforImmunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety? | Full Text | References | PDF (235.5 KB)
  • 2387 Views
  • 66 CrossRef citations
  • 0Altmetric
Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms
Yanna Ko, James Tang, Santosh Sanagapalli, Bong Sik Matthew Kim & Rupert W Leong
Pages: 53-63
Published online: 14 Dec 2015
AbstractforSafety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms | Full Text | References | PDF (505.1 KB)
  • 776 Views
  • 22 CrossRef citations
  • 0Altmetric
The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety
Ryma Ihaddadene & Marc Carrier
Pages: 65-74
Published online: 05 Dec 2015
AbstractforThe use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety | Full Text | References | PDF (238.5 KB)
  • 1850 Views
  • 15 CrossRef citations
  • 0Altmetric
Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues
Focke Ziemssen, Bianka Sobolewska, Heidrun Deissler & Helmut Deissler
Pages: 75-87
Published online: 11 Dec 2015
AbstractforSafety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues | Full Text | References | PDF (889.3 KB)
  • 497 Views
  • 8 CrossRef citations
  • 0Altmetric
Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving
Ignacio Jáuregui, Johannes G Ramaekers, Kazuhiko Yanai, Magí Farré, Esther Redondo, Román Valiente & Luis Labeaga
Pages: 89-98
Published online: 16 Nov 2015
AbstractforBilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving | Full Text | References | PDF (604 KB)
  • 734 Views
  • 18 CrossRef citations
  • 0Altmetric

Drug Safety Evaluations

Article
Tazarotene foam, 0.1%, for the treatment of acne
Jaclyn A Smith BS, Swetha Narahari MD, Dane Hill MD & Steven R Feldman MD, phD
Pages: 99-103
Published online: 30 Nov 2015
AbstractforTazarotene foam, 0.1%, for the treatment of acne | Full Text | References | PDF (207.8 KB)
  • 166 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
The safety of regorafenib for the treatment of gastrointestinal stromal tumors
Piotr Rutkowski & Joanna Stępniak
Pages: 105-116
Published online: 11 Dec 2015
AbstractforThe safety of regorafenib for the treatment of gastrointestinal stromal tumors | Full Text | References | PDF (397.5 KB)
  • 477 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis
Ludger Klimek, Jean Bousquet & David Price
Pages: 117-129
Published online: 23 Dec 2015
AbstractforSafety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis | Full Text | References | PDF (314.4 KB)
  • 344 Views
  • 7 CrossRef citations
  • 0Altmetric

Explore articles